FDA NDC Directory · JSON-LD · Markdown
NDC 11534-200 · HUMAN PRESCRIPTION DRUG · TABLET
| Labeler / Manufacturer | Sunrise Pharmaceutical, Inc. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA040349 |
| Dosage form / route | TABLET · ORAL |
| Active ingredients | SULFASALAZINE (500 mg/1) |
| Marketing started | 20250715 |
| Package count | 3 |
Source: openFDA. Public-domain (CC0).